EMINENZ
Posted - 2 days ago
$KALV buy level. 2bn drug about to be approved.
Night_Owl_Biotech
Posted - 3 days ago
The attachment documents the F2027 revenue multiple of 4 pre-commercial bios with active PDUFA dates including $APLT $KALV $HUMA & $MIST The table also notes valuation related data points around recent royalty investments by 3rd-party investors. Some believe these 3rd-party investments provide a barometer around product valuation. MIST's royalty financing was transacted before MIRT received a refusal to file letter from the FDA for its Etripamil NDA submission. As best we can tell, MIST's royalty financing commitment is still active. KALV & HUMA share prices are down 10%+ from recent third-party stock purchases within the last month. MIST & KALV trade at the lowest FY2027 revenue multiples. This is not investment advice. None of the 4 profiled have any FDA approved products & could go bankrupt if their filings are not approved. As always, we do not use automation so there may be inadvertent mistakes in the raw data $XBI
Carlito84
Posted - 1 week ago
$KALV bought more 🔥
CliffordCapital
Posted - 1 week ago
$KALV loading more here soon
AdiDasRom
Posted - 1 week ago
$KALV
TwongStocks
Posted - 1 week ago
$KALV Another institution reports a significant position. https://www.sec.gov/Archives/edgar/data/1348911/000090266424006561/p24-3216sc13g.htm Vestal Point Capital owns 4m shares, 9.3%
Carlito84
Posted - 1 week ago
$KALV added
TwongStocks
Posted - 1 week ago
$KALV "CWI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital World Investors." CWI is deemed to be the beneficial owner of 3,374,064 shares or 7.8% of the 43,215,472 shares believed to be outstanding. " https://www.sec.gov/Archives/edgar/data/1348911/000142284924000097/SEC13G_Filing.htm
Friesenkoei
Posted - 1 week ago
$KALV 5% after market spike? What's up?
Carlito84
Posted - 1 week ago
$KALV bought more
TwongStocks
Posted - 1 week ago
$KALV KalVista Pharmaceuticals to Present at Upcoming Investor Conferences https://ir.kalvista.com/news-releases/news-release-details/kalvista-pharmaceuticals-present-upcoming-investor-conferences-5
• Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, at 9:10 a.m. EST
• Jefferies London Healthcare Conference on Thursday, November 21, 2024, at 11:00 a.m. GMT
Each presentation will be live webcast on the Company’s website. After the presentations, an audio archive will be available on KalVista’s website for 30 days.
CliffordCapital
Posted - 1 week ago
$KALV bought some
Night_Owl_Biotech
Posted - 2 weeks ago
$KALV announced a royalty financing with DRI on its sebetralstat therapy for HAE with a 6/17/2025 PDUFA date. DRI committed $100MM in exchange for a 5% royalty on sebetralstat sales. Using simple math, this transaction by itself suggests a $2.0B sebetralstat valuation. KALV's market cap is just under $500MM. This is not investment advice because this simple comparison has many flaws & does not consider dozens of other valuation considerations. More important, if the FDA does not approve sebetralstat then KALV could go bankrupt & shareholders could lose 100% of their investment. The attachment compares the KALV/DRI royalty financing agreement with peer transactions of FDA approved therapies (though $IBRX & $VRNA therapies were not approved at the time of their respective agreements). Please let us know if we are missing any FY2024 royalty financing agreements on FDA approved therapies (or those with PDUFA like $SNDX). $ASND As always, our analysis could be wrong.
MakingDreamsReality
Posted - 2 weeks ago
PM mOOvers 👀 $BA - Boeing shares are trading higher after machinists voted to accept a new contract, ending the strike. $ESLT -Elbit Systems Awarded Follow-On $127M Contract For Iron Fist APS, Supporting Bradley IFV Upgrades Over 34-Month Period $ZCAR - Zoomcar Doubles Customer Support Team To Enhance Guest and Host Experience $KALV - KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) $AZPN - Emerson offers to buy rest of AspenTech for $240/share in cash, Aspen Technology Q1 2025 Adj EPS $0.85 May Not Compare To $1.57 Estimate, Sales $215.90M Miss $267.63M Estimate
maphere
Posted - 2 weeks ago
$BCRX $KALV got money today for their HAE treatment, not sure if that's affecting us even though it's not a .prophy
RollingDollars
Posted - 2 weeks ago
$KALV
briefingcom
Posted - 2 weeks ago
$KALV: KalVista Pharmaceuticals priced an underwritten offering of 5,500,000 shares of its common stock at a price of $10.00/share to certain investors https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241104071109KALV&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
TwongStocks
Posted - 2 weeks ago
$KALV $100m royalty agreement signed with DRI Healthcare. https://www.sec.gov/ix?doc=/Archives/edgar/data/1348911/000119312524250223/d904891d8k.htm KALV receives $100m upfront. DRI receives 5% royalty on annual sebetralstat up to $500m. 1.10% royalty on annual sales of $500m-$750m. $0.25% royalty on annual sales above $750m. If sebetralstat is approved by September 30, 2025, KALV can receive an optional payment of $22m from DRI. If KALV elects the optional $22m payment, DRI's 5% royalty increases to 6%.
DonCorleone77
Posted - 2 weeks ago
$KALV KalVista 5.5M share Secondary priced at $10.00 Jefferies, BofA, TD Cowen and Stifel acted as joint book running managers for the offering.
TwongStocks
Posted - 10/29/24
$KALV -Phase 3 trial data show that early treatment is correlated with shorter attack duration -Rigorous comparison of Phase 3 results for oral sebetralstat and pivotal trial results of IV recombinant C1-inhibitor for on-demand treatment of HAE attacks shows no differences in time to beginning of symptom relief https://ir.kalvista.com/news-releases/news-release-details/kalvista-pharmaceuticals-presents-new-sebetralstat-data-2024 Hopefully, continues to move upward as it gets closer to the PDUFA date.
Fugazi_
Posted - 1 month ago
$KALV what do people expect on moves, KALV went to 40$ during their phase 3 data announcement in 2021 for KVD900 oral
justiceforb_85
Posted - 1 month ago
$KALV looking forward to PDUFA! https://www.nejm.org/doi/full/10.1056/NEJMoa2314192
uptrend98
Posted - 1 month ago
$KALV this about to blow up or what?
pepe7
Posted - 1 month ago
$KALV
shared_alerts
Posted - 09/30/24
-09/30/2024-
📉 SCANNER UPDATE📈 $MNPR $CNEY $KALV $LZM ↩️
AdiDasRom
Posted - 09/30/24
$KALV "KalVista Announces Submission of Additional Marketing Authorization Applications for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema"
pepe7
Posted - 09/29/24
$KALV
GambitMentality
Posted - 09/27/24
Today’s #StockMarket EOD Biggest Gainers by %, led by $KALV $JG and $PGHL to lead the TOP 3
monzelo
Posted - 09/27/24
$KALV Hasta Kalvista..baby